#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should understand that cannabis does not provide reliable sleep benefits and may instead create dependency cycles, making it a problematic recommendation for patients with insomnia. This evidence shifts the risk-benefit calculation for sleep-related cannabis use, requiring clinicians to counsel patients away from self-medication with cannabis and toward evidence-based sleep interventions. Patients currently using cannabis for sleep need assessment for dependence risk and discussion of more effective alternatives like cognitive behavioral therapy for insomnia.
A 2025 systematic review examining cannabis use for sleep disorders found that cannabis does not reliably improve key sleep metrics such as sleep duration or sleep maintenance, contradicting widespread patient perception of its efficacy. While some users report subjective improvements in sleep onset, the evidence suggests these benefits may be offset by tolerance development and the emergence of cannabis use disorder, particularly in individuals using cannabis nightly for sleep. Regular cannabis use for insomnia appears to create a problematic cycle where patients become psychologically and potentially physically dependent on the substance while experiencing diminishing therapeutic returns. The review highlights that patients may attribute initial perceived improvements to cannabis while overlooking the development of tolerance and withdrawal symptoms that occur with chronic use, including rebound insomnia upon cessation. Clinicians should counsel patients seeking cannabis for sleep that evidence does not support its use as a primary therapeutic agent and that dependence risk substantially increases with frequent dosing. When discussing sleep management with patients, practitioners should emphasize evidence-based alternatives such as cognitive behavioral therapy for insomnia while being prepared to address cannabis use patterns that may be maintaining or worsening sleep quality.
“The evidence on cannabis for sleep is genuinely mixed, and what we’re seeing in the literature suggests that while some patients report subjective improvement in sleep onset, we lack robust data on long-term efficacy and dependency risk, which means I counsel patients that this remains a reasonable area for further study but not yet a first-line approach I’d confidently recommend.”
🛌 While many patients report subjective sleep improvement with cannabis use, emerging evidence suggests this perceived benefit may not reflect objective sleep architecture changes and could mask underlying sleep disorders requiring evidence-based treatment. The dependency potential is particularly concerning given that tolerance develops relatively quickly, potentially leading patients to escalate use while experiencing diminishing sleep benefits—a pattern that complicates both sleep quality and overall health outcomes. Clinicians should be cautious about cannabis as a first-line or long-term sleep aid, especially since alternatives like cognitive behavioral therapy for insomnia (CBT-I) have robust evidence supporting sustained efficacy without dependency risk. When patients report using cannabis for sleep, a thorough sleep history and consideration of screening for sleep disorders (apnea, restless leg syndrome, circadian misalignment) becomes essential before attributing symptom relief to the cannabis itself. Recommending evidence-based sleep hygiene approaches and referring appropriate patients for formal sleep medicine evaluation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
